Category Archives: Endocrinology

Dr. Marcus D. Goncalves Inducted into the American Society for Clinical Investigation – Weill Cornell Medicine Newsroom

Dr. Marcus D. Goncalves, the Ralph L. Nachman, M.D. Research Scholar and an assistant professor of medicine in the Division of Endocrinology, Diabetes and Metabolism at Weill Cornell Medicine, has been elected as a member of the American Society for Clinical Investigation (ASCI) for 2024.

The ASCI is one of the nations oldest nonprofit medical honor societies and focuses on the unique role of physician-scientists in research, clinical care and medical education. It is comprised of more than 3,000 physician-scientists representing all medical specialties in the upper ranks. ASCI members are leaders in their fields in translating laboratory findings into clinical advancements. Dr. Goncalves is among 100 new members elected this year and will be officially inducted at the organizations annual meeting in April.

Its a high honor for me to be included in this group, said Dr. Goncalves, who is also an assistant professor of biochemistry at Weill Cornell Medicine. Im very grateful to the selection committee and the people who nominated me because ASCI membership represents a significant milestone in my career and has been a dream of mine ever since I was an MD-PhD student.

Dr. Goncalves clinical research encompasses the intersection between endocrinology and cancer biology, with his lab focusing on the effects of diet and cancer on the host tissues that regulate systemic nutrient metabolism. We investigate how cancer impacts systemic metabolism and, on the contrary, how systemic hormones and metabolites can promote or slow tumor growth, he said.

A particular focus of Dr. Goncalves research is cachexia, a debilitating wasting syndrome that involves muscle and fat loss and often occurs in people with advanced cancer. He is co-leader of the Cancer Cachexia Action Network (CANCAN), which was established in 2022 and funded through a Cancer Grand Challenges award from the National Cancer Institute and Cancer Research UK, and seeks to explore the underlying mechanisms of cachexia in cancer. The team consists of clinicians, patient advocates and scientists with expertise in cancer, metabolism, immunology and more from 14 institutions across the United States and the U.K.

With cachexia, some people may lose weight because theyre not eating. Others, with high metabolism, may lose weight despite eating more than they need, Dr. Goncalves said. In either case, weight loss from cachexia increases the risk of death and leads to poor outcomes in terms of treatment response. Theres no known mechanism for why cachexia develops or how to treat it, he said. My goal and our research teams goal is to try and identify the different subtypes of people who are experiencing cancer-related weight loss and develop targeted treatments for the condition.

Election into the ASCI, which is based on outstanding scholarly achievement, will provide Dr. Goncalves with the opportunity to engage with other physician-scientists who are conducting innovative research in a variety of medical specialties. Its an honor to be elected to the ASCI at this stage of my career, he said, and it validates the work weve been doing.

Originally posted here:

Dr. Marcus D. Goncalves Inducted into the American Society for Clinical Investigation - Weill Cornell Medicine Newsroom

Alpha Lipoic Acid for Diabetic Neuropathy: Does It Work? – diaTribe Foundation

Alpha-lipoic acid is an omega-3 fatty acid naturally found in food. Some studies suggest that supplementing with ALA may play a role in treating diabetic neuropathy.

You already know how important diet is for keeping a lid on diabetes symptoms and glucose levels.

If you live with diabetic neuropathy, a type of nerve damage resulting from diabetes, certain natural compounds found in foods may help slow progression and relieve symptoms.

One is called alpha-lipoic acid (ALA), and some studies suggest it may play a role in treating neuropathy. Additionally, as an antioxidant, it may be beneficial for keeping your cells and organs like your brain and liver healthy.

What does research say so far about ALA? Lets find out.

ALA is an antioxidant found in foods like broccoli, spinach, and red meat. Your bodys cells also make it in small amounts.

Antioxidants are thought to protect cells against damage that, over time, can lead to chronic diseases making them crucial components of your immune system. Fruit, vegetables, and nuts are a few examples of foods rich in antioxidants. ALA is one antioxidant that early research has found may be beneficial if you have diabetes.

ALA is considered more of a supplemental therapy that may have effects on diabetic neuropathy, says Dr. Maamoun Salam, an associate professor of endocrinology at Washington University School of Medicine in St. Louis. It also has some glucose-lowering effects.

Alpha-lipoic acid is not to be confused with alpha-linolenic acid, an omega-3 fatty acid your body does not make. Same initials, different compounds.

When you have chronically high blood sugar, it can damage nerves and the small blood vessels that nourish your nerves. Thats how diabetic neuropathy is developed.

ALA may help neuropathy in multiple ways. On its own, its an effective antioxidant. Taking an ALA dietary supplement can also boost vitamin C and E levels, which in turn can increase your bodys supply of glutathione, another antioxidant. Together, these two antioxidants may clear free radicals molecules that can cause cell damage more efficiently.

Thats particularly important when you have diabetes as people with the condition either produce more free radicals, clear them slower, or both. Fewer free radicals may mean less nerve damage and milder diabetic neuropathy symptoms.

Dr. Salam points to a trio of trials of ALA in people with diabetes that showed improvements in pain, numbness, and paresthesia. However, he notes, the sample sizes were small and the study durations short, so its difficult to conclude whether ALA is effective for diabetic neuropathy.

For people with diabetes, ALA may also extend beyond diabetic neuropathy treatment and aid blood sugar management.

Researchers suggest ALA works by binding to certain insulin receptors in liver cells. The compound has been called an insulin-mimetic agent, meaning it mimics the effects of insulin. Though research is limited to animal studies, the increase in the antioxidant glutathione that results from ALA supplementation may play a role in glucose management.

All cells in the body naturally produce some ALA. You can get more through foods such as:

Broccoli

Brussels sprouts

Organ meats like liver

Red meat

Rice bran

Tomatoes

Spinach

Yeast

You can also get it from dietary supplements, though its important to note these are expensive. Since ALA is both water- and fat-soluble, you dont need to take it with food like you would with a purely fat-soluble compound such as vitamin D.

ALA is a dietary supplement and therefore does not require the same level of evidence and rigorous scientific testing as a pharmaceutical medicine. Similar to other dietary supplements, it only needs to be considered safe and effective by the U.S. Food and Drug Administration to be sold.

ALA is not generally found in tablets or capsules greater than 600 mg because studies suggest that higher doses are not more effective. Side effects can include:

Rare cases have been reported in which ALA appears to have induced insulin autoimmune syndrome, a rare type of hypoglycemia caused by too many insulin autoantibodies.

Sometimes I will offer it as add-on therapy for those who do not wish to switch to another approved agent or increase the dose of an agent they are using because they want to avoid side effects, said Salam.

Speak to a healthcare professional before trying dietary supplements like ALA. Supplements are no substitute for being mindful about diet, physical activity, maintaining a healthy weight, and taking any and all prescription medications as directed.

Learn more about treatments for diabetic neuropathy here:

Go here to read the rest:

Alpha Lipoic Acid for Diabetic Neuropathy: Does It Work? - diaTribe Foundation

Changed Endocrinology in Postmenopausal Women: A Comprehensive View – Cureus

Specialty

Please choose I'm not a medical professional. Allergy and Immunology Anatomy Anesthesiology Cardiac/Thoracic/Vascular Surgery Cardiology Critical Care Dentistry Dermatology Diabetes and Endocrinology Emergency Medicine Epidemiology and Public Health Family Medicine Forensic Medicine Gastroenterology General Practice Genetics Geriatrics Health Policy Hematology HIV/AIDS Hospital-based Medicine I'm not a medical professional. Infectious Disease Integrative/Complementary Medicine Internal Medicine Internal Medicine-Pediatrics Medical Education and Simulation Medical Physics Medical Student Nephrology Neurological Surgery Neurology Nuclear Medicine Nutrition Obstetrics and Gynecology Occupational Health Oncology Ophthalmology Optometry Oral Medicine Orthopaedics Osteopathic Medicine Otolaryngology Pain Management Palliative Care Pathology Pediatrics Pediatric Surgery Physical Medicine and Rehabilitation Plastic Surgery Podiatry Preventive Medicine Psychiatry Psychology Pulmonology Radiation Oncology Radiology Rheumatology Substance Use and Addiction Surgery Therapeutics Trauma Urology Miscellaneous

Go here to see the original:

Changed Endocrinology in Postmenopausal Women: A Comprehensive View - Cureus

Cone physician in Rockingham Co. is top national lifestyle doc in fight against diabetes – Greensboro News & Record

REIDSVILLE Local endocrinologist Gebreselassie (Gebre) Nida has recently been recognized as a national leader in treatment of diabetes and promotion of healthy lifestyles.

The prestigious medical report card, the Marquis Whos Who, included Nida in its recent directory of top physicians, according to Cone Health officials.

Nida practices at Cone Healths Reidsville Endocrinology Associates.

While Nida is an accomplished endocrinology and diabetes physician, he is becoming known as an expert in the growing field of lifestyle medicine, according to Cone spokesman Doug Allred.

A marathon runner who practices a health lifestyle himself, Nida is passionate about preventing and reversing Type 2 diabetes and many lifestyle-related chronic diseases, Allred said in a news release.

Lifestyle medicine uses proven methods to make changes in diet, exercise and stress management to improve health. Much of the system centers on removing the root causes of chronic diseases, such as ultra-processed foods and drinks, from the diet.

Nidas vision is to expand this effective and better way of healing, Allred said in the release.

He credits his leaders and team members for the success of the Lifestyle Medicine Steering Committee at Cone Health.

Nida serves as a board member for Annie Penn Hospital Foundation and is the lead physician for the Rockingham County Diabetes Task Force. He leads and contributes to the Greensboro Chapter of Walk with a Doc.

A native of rural Ethiopia, Nida grew up tending animals in rugged conditions.

He raised cattle and sheep in an area without electricity and running water.

And because his father valued education, Nida was allowed to attend an elementary school he reached by walking one hour each way.

By age 12, Nida left home to pursue more specialized education and eventually made it to Addis Ababa University where he earned medical degree in 1999.

Soon after, Nida and his wife, Ethiopia Desta, immigrated to the United States where he pursued postgraduate studies, a residency in internal medicine and a fellowship in endocrinology, diabetes, and metabolism at Wayne State University in Michigan.

Nida joined Cone Health in 2012 where he recently added the new specialty Lifestyle Medicine with a new board certification from American College of Lifestyle Medicine.

An outdoors enthusiast, Nida has competed in 32 marathons, including five Boston Marathon races, and three major world marathons with a personal best time of 2:47:09 at age 48.

Follow this link:

Cone physician in Rockingham Co. is top national lifestyle doc in fight against diabetes - Greensboro News & Record

Integrating Precision Medicine for Obesity into Type 2 Diabetes Management: A Comprehensive Overview from Past to … – Physician’s Weekly

The following is a summary of Precision medicine of obesity as an integral part of type 2 diabetes management past, present, and future, published in the December 2023 issue of Diabetes & Endocrinology by Szczerbinski, et al.

Several metabolic problems may be ascribed to obesity, which is a condition that is both difficult and varied. One of these metabolic problems is type 2 diabetes. Many people do not achieve lasting weight loss or improvements in metabolic health as a consequence of the fact that the treatment options that are now accessible for obesity are insufficient for some individuals.

It contributed to the fact that many people do not achieve persistent weight loss. The emphasis of this review is on metabolic consequences and the potential implications of these repercussions for personalized therapy of the illness. The study highlighted the developments that have taken place in the field of obesity genetics throughout the last ten years, with a specific focus on major discoveries that have taken place during the preceding five years.

There was also a discussion in this article on the potential role that genetics might have in determining the effectiveness of weight loss programs. Lastly, they provide a vision for the future of precision obesity therapy, which entails the development of an algorithm for the management of several illnesses that are based on obesity and tackles both obesity and the symptoms that accompany it. The algorithm will be used to treat obesity both directly and indirectly. On the other hand, the full realization of its potential and the improvement of metabolic health outcomes would need more research and concerted efforts.

Source: sciencedirect.com/science/article/abs/pii/S2213858723002322

Excerpt from:

Integrating Precision Medicine for Obesity into Type 2 Diabetes Management: A Comprehensive Overview from Past to ... - Physician's Weekly

Deciphering Diabetes Heterogeneity: Advancing Toward Precision Medicine in Diabetes Care – Physician’s Weekly

The following is a summary of Understanding diabetes heterogeneity: key steps towards precision medicine in diabetes, published in the December 2023 issue of Diabetes & Endocrinology by Leslie, et al.

Diabetes is a disorder that shows a great deal of heterogeneity. Yet, it can be diagnosed by detecting a single blood-borne metabolite, glucose, regardless of the underlying cause of the ailment. Disease categorization may become complicated, which might impede progress in research and medical treatment even though it is beneficial from a practical standpoint. For a study, researchers sought to discuss the heterogeneity of diabetes and highlight emerging techniques that might make treatment easier.

The approaches included combining three disease models that apply to all types of diabetes. These models are the gradient model, the threshold model, and the palette model, each individually. Multiple mechanisms that are meant to avoid or bypass metabolic dysfunction are responsible for preventing the further worsening of existing diabetes and the eventual appearance of problems associated with diabetes. Once diabetes has been established, these risks are maintained under control.

The effect of any disease risk factor will differ from person to person based on their history, diabetes-related tendencies, and environmental exposures. This means that the impact of any given disease risk factor will vary. Using precision medicine to define the resultant variability within diabetes, both in terms of the risk of complications and the risk of diabetes itself, can enhance health outcomes in the present and provide light on potential paths for innovative treatment in the future.

Source: sciencedirect.com/science/article/abs/pii/S2213858723001596

View post:

Deciphering Diabetes Heterogeneity: Advancing Toward Precision Medicine in Diabetes Care - Physician's Weekly